GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » K Pharma Inc (TSE:4896) » Definitions » Stock Based Compensation

K Pharma (TSE:4896) Stock Based Compensation : 円0 Mil (TTM As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is K Pharma Stock Based Compensation?

K Pharma's Stock Based Compensation for the three months ended in Mar. 2024 was 円0 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2024 was 円0 Mil.


K Pharma Stock Based Compensation Historical Data

The historical data trend for K Pharma's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

K Pharma Stock Based Compensation Chart

K Pharma Annual Data
Trend Dec21 Dec22 Dec23
Stock Based Compensation
- - -

K Pharma Quarterly Data
Dec21 Dec22 Jun23 Sep23 Dec23 Mar24
Stock Based Compensation Get a 7-Day Free Trial - - - - -

K Pharma Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円0 Mil.


K Pharma Stock Based Compensation Related Terms

Thank you for viewing the detailed overview of K Pharma's Stock Based Compensation provided by GuruFocus.com. Please click on the following links to see related term pages.


K Pharma (TSE:4896) Business Description

Traded in Other Exchanges
N/A
Address
7-7-7 Roppongi, Minato-ku, Tokyo, JPN, 106-0032
K Pharma Inc is a company involved in Research, development, manufacturing, sales and marketing of pharmaceutical products and regenerative medicine products. It is involved in studying of iPs cells in regnerative medecine to treat neurological conditions such as cerebral infarction and SCI.

K Pharma (TSE:4896) Headlines

No Headlines